We are live on ! Find out more

3,448 hedge funds and large institutions have $181B invested in Merck in 2025 Q1 according to their latest regulatory filings, with 180 funds opening new positions, 1,347 increasing their positions, 1,599 reducing their positions, and 278 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more call options, than puts

Call options by funds: $2.57B | Put options by funds: $2.32B

0.43% more ownership

Funds ownership: 78.27%78.7% (+0.43%)

4% less funds holding

Funds holding: 3,6083,448 (-160)

8% less capital invested

Capital invested by funds: $197B → $181B (-$16.1B)

11% less funds holding in top 10

Funds holding in top 10: 7365 (-8)

16% less repeat investments, than reductions

Existing positions increased: 1,347 | Existing positions reduced: 1,599

35% less first-time investments, than exits

New positions opened: 180 | Existing positions closed: 278

Holders
3,448
Holders Change
-160
Holders Change %
-4.43%
% of All Funds
46.23%
Holding in Top 10
65
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-10.96%
% of All Funds
0.87%
New
180
Increased
1,347
Reduced
1,599
Closed
278
Calls
$2.57B
Puts
$2.32B
Net Calls
+$255M
Net Calls Change
+$17.9M
Name Holding Trade Value Shares
Change
Change in
Stake
KCM
276
Kornitzer Capital Management
Kansas
$47.3M -$1.07M -11,457 -2%
QCM
277
QRG Capital Management
Illinois
$47M -$493K -5,275 -1%
AG
278
AIA Group
Hong Kong
$46.5M -$2.64M -28,235 -5%
DLA
279
Douglas Lane & Associates
New York
$45.9M -$763K -8,174 -2%
WT
280
Whittier Trust
California
$45.8M +$228K +2,446 +0.5%
RCM
281
Radnor Capital Management
Pennsylvania
$45.6M -$1.24M -13,268 -3%
VLKIM
282
Van Lanschot Kempen Investment Management
Netherlands
$45.2M -$121M -1,292,388 -72%
MML Investors Services
283
MML Investors Services
Massachusetts
$45.1M +$858K +9,190 +2%
Susquehanna International Group
284
Susquehanna International Group
Pennsylvania
$45M -$91.4M -978,665 -66%
EF
285
Empowered Funds
Pennsylvania
$45M +$16.8M +180,118 +56%
GC
286
Guggenheim Capital
Illinois
$44.9M +$10.5M +112,579 +29%
P
287
&Partners
Tennessee
$44.8M +$7.52M +80,574 +19%
RG
288
Rathbones Group
United Kingdom
$44.7M -$71.4M -764,209 -61%
AAP
289
Aristotle Atlantic Partners
Florida
$44.6M
RT
290
Rockland Trust
Massachusetts
$44.3M +$7.12M +76,223 +18%
KBG
291
Kahn Brothers Group
New York
$44.2M -$1.55M -16,633 -3%
BBVA
292
Banco Bilbao Vizcaya Argentaria
Spain
$44.1M +$98.1K +1,051 +0.2%
SPIA
293
Steward Partners Investment Advisory
New York
$44.1M +$698K +7,481 +2%
Pathstone Holdings
294
Pathstone Holdings
New Jersey
$43.9M -$2.89M -30,924 -6%
FMI
295
Factory Mutual Insurance
Massachusetts
$43.8M -$6.65M -71,200 -13%
Assenagon Asset Management
296
Assenagon Asset Management
Luxembourg
$43.7M -$20.8M -222,494 -31%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
297
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$43.7M -$175M -1,878,640 -79%
II
298
IFM Investors
Australia
$43.5M -$351K -3,764 -0.8%
Fidelity International
299
Fidelity International
Bermuda
$43.5M +$24.8M +265,942 +122%
BCIM
300
British Columbia Investment Management
British Columbia, Canada
$43.4M -$153K -1,638 -0.3%

MRK Hedge Fund Activity: Q1 2025 in Review

3,448 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2025, worth a combined $181B — down 8.2% from $197B a quarter earlier.

Sellers outnumbered buyers: 278 funds closed out of MRK and 180 opened new positions — a net loss of 98 holders — while 1,599 trimmed existing stakes and 1,347 added.

The largest buyer was Charles Schwab, adding an estimated $2.72B. The largest seller was Capital World Investors, exiting entirely with an estimated $787M sold.

  • 3,448 institutional investors held Merck (MRK) as of Q1 2025, down from 3,608 in Q4 2024.
  • Funds reported $181B of Merck stock for Q1 2025, down 8.2% quarter-over-quarter.
  • 180 funds opened new Merck positions in Q1 2025 and 278 closed out, a net change of -98 holders.
  • The largest Merck buyer in Q1 2025 was Charles Schwab, an estimated $2.72B added.
  • The largest Merck seller in Q1 2025 was Capital World Investors, an estimated $787M sold.

Based on aggregated 13F filings for Q1 2025.